Radiation Trends & Developments: Key Takeaways from the 2024 ASTRO Meeting | ZERO Prostate Cancer
Be among the first to hear about prostate cancer research updates from the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting! This webinar features: 💬 A discussion led by expert radiation oncologist Dr. Jonathan Leeman 🆕 Updates on innovative treatment developments 💡 Insights into the latest trends shaping patient care 🩺 Potential treatment options that could save and extend lives For more information, visit zerocancer.org.
▶︎
High-risk prostate cancer: what patients and physicians should know in 2026
▶︎
Surgery vs. Radiation with Dr. Shaakir Hasan - ZERO Prostate Cancer Summit 2022
▶︎
Radiation & Side Effects For Prostate Cancer | Mack Roach III, MD & Q+A with Mark Moyad, MD #PCRI
▶︎
Radiation therapy for prostate cancer: the basics
▶︎
Prostate Cancer Cure Explained: PSA, Recurrence, and Survival
▶︎
Prostate Cancer Side Effects & How to Manage Them | Minimizing Side Effects & Risk After Radiation
▶︎
Spot Radiation & Advanced #ProstateCancer | Michael Steinberg, MD & Mark Moyad, MD, MPH | #PCRI
▶︎
Managing Biochemical Recurrence After Prostate Radiation w/ Dr. Amar Kishan | Urology Ep. 200
▶︎
Advanced #ProstateCancer Treatments + Extended Q+A | #MarkScholzMD & #MarkMoyadMD #PCRI
▶︎
Prostate cancer: State-of-the-art diagnosis and non-invasive treatment
▶︎
Clinical Case Discussions in Ocular Surface Disease with Dr. Laura McLaughlin
▶︎
Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows
▶︎
Prostate Cancer Diagnostics and Imaging: A Town Hall Discussion | ZERO Prostate Cancer
▶︎
Prostate brachytherapy (seed implants) in 2026 explained for patients and physicians
▶︎
SBRT & CyberKnife: Who Can Skip ADT/Lupron in Prostate Cancer? with Dr. Jonathan Haas | EP 134
▶︎
Prostate Cancer in 2024: Recent Updates and Treatment Advances
▶︎
Prostate Brachytherapy - Low dose rate or high dose rate: what you need to know - Dr. Juanita Crook
▶︎
Active Surveillance: Past, Present, and Future
▶︎
Intermediate Risk Prostate Cancer
▶︎